ADC Therapeutics Statistics
Total Valuation
ADCT has a market cap or net worth of $523.39 million. The enterprise value is $709.86 million.
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026, before market open.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ADCT has 127.19 million shares outstanding. The number of shares has increased by 30.78% in one year.
| Current Share Class | 127.04M |
| Shares Outstanding | 127.19M |
| Shares Change (YoY) | +30.78% |
| Shares Change (QoQ) | +10.15% |
| Owned by Insiders (%) | 6.33% |
| Owned by Institutions (%) | 40.80% |
| Float | 98.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.53 |
| Forward PS | 6.65 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.73 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.37
| Current Ratio | 4.37 |
| Quick Ratio | 4.14 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.05 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -20.56% |
| Return on Invested Capital (ROIC) | -26.84% |
| Return on Capital Employed (ROCE) | -41.94% |
| Weighted Average Cost of Capital (WACC) | 12.40% |
| Revenue Per Employee | $421,539 |
| Profits Per Employee | -$738,979 |
| Employee Count | 193 |
| Asset Turnover | 0.25 |
| Inventory Turnover | 33.42 |
Taxes
In the past 12 months, ADCT has paid $1.02 million in taxes.
| Income Tax | 1.02M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +252.48% in the last 52 weeks. The beta is 1.95, so ADCT's price volatility has been higher than the market average.
| Beta (5Y) | 1.95 |
| 52-Week Price Change | +252.48% |
| 50-Day Moving Average | 4.07 |
| 200-Day Moving Average | 3.75 |
| Relative Strength Index (RSI) | 59.42 |
| Average Volume (20 Days) | 828,486 |
Short Selling Information
The latest short interest is 4.90 million, so 3.85% of the outstanding shares have been sold short.
| Short Interest | 4.90M |
| Short Previous Month | 4.11M |
| Short % of Shares Out | 3.85% |
| Short % of Float | 4.95% |
| Short Ratio (days to cover) | 5.31 |
Income Statement
In the last 12 months, ADCT had revenue of $81.36 million and -$142.62 million in losses. Loss per share was -$1.12.
| Revenue | 81.36M |
| Gross Profit | -26.16M |
| Operating Income | -106.10M |
| Pretax Income | -141.61M |
| Net Income | -142.62M |
| EBITDA | -105.39M |
| EBIT | -106.10M |
| Loss Per Share | -$1.12 |
Full Income StatementBalance Sheet
The company has $261.34 million in cash and $439.55 million in debt, with a net cash position of -$178.21 million or -$1.40 per share.
| Cash & Cash Equivalents | 261.34M |
| Total Debt | 439.55M |
| Net Cash | -178.21M |
| Net Cash Per Share | -$1.40 |
| Equity (Book Value) | -185.83M |
| Book Value Per Share | -1.48 |
| Working Capital | 236.17M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$141.17 million and capital expenditures -$264,000, giving a free cash flow of -$141.44 million.
| Operating Cash Flow | -141.17M |
| Capital Expenditures | -264,000 |
| Depreciation & Amortization | 705,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -141.44M |
| FCF Per Share | -$1.11 |
Full Cash Flow StatementMargins
Gross margin is -32.16%, with operating and profit margins of -130.41% and -175.31%.
| Gross Margin | -32.16% |
| Operating Margin | -130.41% |
| Pretax Margin | -174.06% |
| Profit Margin | -175.31% |
| EBITDA Margin | -129.54% |
| EBIT Margin | -130.41% |
| FCF Margin | n/a |
Dividends & Yields
ADCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -30.78% |
| Shareholder Yield | -30.78% |
| Earnings Yield | -26.83% |
| FCF Yield | -26.60% |
Analyst Forecast
The average price target for ADCT is $7.75, which is 88.34% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.75 |
| Price Target Difference | 88.34% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 35.85% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ADCT has an Altman Z-Score of -6.68 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.68 |
| Piotroski F-Score | 4 |
